companydata.dkcompanydata.dk

Supar Health ApS: Financial statements 2024

CVR: 41298790

Source: annual report 2024, Danish Business Authority

01/10/2023 – 30/09/2024

Supar Health ApS (CVR 41298790) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 34,768. The solvency ratio was 100%.

Equity
DKK 34,768
Total Assets
DKK 34,768

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-0035K-
2023-006800
2022--040K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Supar Health ApS: The 2023 annual report is outApr 7, 2024

Supar Health ApS has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK 0.

About Supar Health ApS

Supar Health ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Aetas ApS. The management consists of Thomas Gielsgaard Hargreave. The company is owned by Aetas Healthcare ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -332,648 and a net result of DKK -332,474 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK -297,658.

Source: annual report 2025, Danish Business Authority

Other financial years